We further demonstrated the anti-angiogenic capacity of quininib by examining gene expression of angiogenic factors in xenograft tumours and found that the expression of IL6, IL8, NRP2, VEGFA and FGF1 was reduced by quininib treatment. Here, NRP2 is linked to neoplasm.